Cite
HARVARD Citation
Chua, J. et al. (2021). Short‐duration treatment with the novel non‐nucleoside inhibitor CDI‐31244 plus sofosbuvir/velpatasvir for chronic hepatitis C: An open‐label study. Journal of medical virology. 93 (6), pp. 3752-3760. [Online].